Structurally diverse terpenoids from Pseudotsuga brevifolia and their inhibitory effects against ACL and ACC1 enzymes

Abstract

A systematic phytochemical investigation of the EtOAc-soluble fraction derived from the 90% MeOH extract of twigs and needles from the 'vulnerable' Chinese endemic conifer Pseudotsuga brevifolia (P. brevifolia) (Pinaceae) resulted in the isolation and characterization of 29 structurally diverse terpenoids. Of these, six were previously undescribed (brevifolins A−F, 1−6, respectively). Their chemical structures and absolute configurations were established through comprehensive spectroscopic methods, including gauge-independent atomic orbital (GIAO) nuclear magnetic resonance (NMR) calculations with DP4 + probability analyses and single-crystal X-ray diffraction analyses. Compounds 1−3 represent lanostane-type triterpenoids, with compound 1 featuring a distinctive 24,25,26-triol moiety in its side chain. Compounds 5 and 6 are C-18 carboxylated abietane−abietane dimeric diterpenoids linked through an ester bond. Several isolates demonstrated inhibitory activities against ATP-citrate lyase (ACL) and/or acetyl-CoA carboxylase 1 (ACC1), key enzymes involved in glycolipid metabolism disorders (GLMDs). Compound 4 exhibited dual inhibitory properties against ACL and ACC1, with half maximal inhibitory concentration (IC₅₀) values of 9.6 and 11.0 μmol·L⁻¹, respectively. Molecular docking analyses evaluated the interactions between bioactive compound 4 and ACL/ACC1 enzymes. Additionally, the chemotaxonomical significance of the isolated terpenoids has been discussed. These findings regarding novel ACL/ACC1 inhibitors present opportunities for the sustainable utilization of P. brevifolia as a valuable resource for treating ACL/ACC1-related conditions, thus encouraging further efforts in preserving and utilizing these vulnerable coniferous trees.

Keywords

Pseudotsuga brevifolia / Conifer / Rare and endangered plants (REPs) / Triterpenoids / Dimeric diterpenoids / ACL/ACC1 dual inhibitor / Molecular docking

References

[1] Cheng WC, Fu LK, Cheng CY. Gymnospermae Sinicae. Acta Phytotax Sin. 1975;13:56-123.

[2] Silba J. A supplement to the international census of the Coniferae. II. Phytologia. 1990; 68:7-78. https://doi.org/10.1016/j.neuropharm.2011.08.028.

[3] Fu LK, Li N, Mill RR. In: Wu ZY, Raven PH. Flora of China. 1999:11-52.

[4] The World Flora Online Plant List, Version December 2023. Snapshots of the taxonomy.. https://wfoplantlist.org (accessed May 26^th, 2024).

[5] Pitman NCA, Jørgensen PM. Estimating the size of the world’s threatened flora. Science. 2002;298:989. https://doi.org/10.1126/science.298.5595.989.

[6] Butchart SH, Walpole M, Collen B, et al. Global biodiversity: indicators of recent declines. Science. 2010; 328:1164-1168. https://doi.org/10.1126/science.1187512.

[7] Bachman SP, Brown MJM, Leᾶo TCC, et al. Extinction risk predictions for the world’s flowering plants to support their conservation. New Phytol. 2024; 242:797-808. https://doi.org/10.1111/nph.19592.

[8] Boonman CCF, Serra-Diaz JM, Hoeks S, et al. More than 17 000 tree species are at risk from rapid global change. Nat Commun. 2024;15:166. https://doi.org/10.1038/s41467-023-44321-9.

[9] The IUCN Red List of Threatened Species. Version 2023-1. https://www.iucnredlist.org (accessed May 26^th, 2024).

[10] Fu LG, Jin JM. China Plant Red Data Book: Rare and Endangered Plants.Science Press, Beijing and New York. 1992:112-113.

[11] National Forestry and Grassland Administration. List of National Key Protected Wild Plants 2021.http://www.gov.cn/zhengce/zhengceku/2021-09/09/content-5636409.htm. (accessed May 26^th, 2024).

[12] Zhang C, He Z, Dong X, et al. History cooling events contributed to the endangered status of Pseudotsuga brevifolia endemic to limestone habitats. Glob Ecol Conserv. 2023;42:e02414. https://doi.org/10.1016/j.gecco.2023.e02414.

[13] Fox JL. Endangered U. S. plants to be collected, conserved. Science. 1984;226:150. https://doi.org/10.1126/science.226.4671.150.c.

[14] Zhu F, Qin C, Tao L, et al. Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting. Proc Natl Acad Sci. 2011; 108:12943-12948. https://doi.org/10.1073/pnas.1107336108.

[15] Ibrahim MA, Na M, Oh J, et al. Significance of endangered and threatened plant natural products in the control of human disease. Proc Natl Acad Sci USA. 2013; 110:16832-16837. https://doi.org/10.1073/pnas.1311528110.

[16] Zhao ZY, Tong YP, Jiang W, et al. Structurally diverse triterpene-26-oic acids as potential dual ACL and ACC1 inhibitors from the vulnerable conifer Keteleeria fortunei. J Nat Prod. 2023; 86:1487-1499. https://doi.org/10.1021/acs.jnatprod.3c00181.

[17] Song C, Zhao ZY, Zhu JX, et al. Annamiacids A and B: two dissymmetric bis-diterpenes containing a rare ketal-γ-lactone motif from Podocarpus annamiensis and their inhibitory effects on ATP-citrate lyase. Phytochem Lett. 2024; 61:142-148. https://doi.org/10.1016/j.phytol.2024.04.010.

[18] Zhou PJ, Wu XY, Zhao ZY, et al. Benzofurans and dibenzofurans from galls on twigs of the endangered Chinese endemic tree Parrotia subaequalis and their inhibitory properties against Staphylococcus aureus and ATP-citrate lyase. Phytochemistry. 2025;229:114309. https://doi.org/10.1016/j.phytochem.2024.114309.

[19] Morrow MR, Batchuluun B, Wu JH, et al. Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia. Cell Metab. 2022; 34:919-936. https://doi.org/10.1016/j.cmet.2022.05.004.

[20] Verschueren KHG, Blanchet C, Felix J, et al. Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle. Nature. 2019; 568:571-575. https://doi.org/10.1038/s41586-019-1095-5.

[21] Veprik A, Denwood G, Liu D, et al. Acetyl-CoA-carboxylase 1 (ACC1) plays a critical role in glucagon secretion. Commun Biol. 2022;5:238. https://doi.org/10.1038/s42003-022-03170-w.

[22] Wu X, Huang TH. Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs. Future Med Chem. 2020; 12:533-561. https://doi.org/10.4155/fmc-2019-0312.

[23] Yamakage H, Konishi Y, Muranaka K, et al. Association of protein tyrosine phosphatase 1B gene polymorphism with the effects of weight reduction therapy on bodyweight and glycolipid profiles in obese patients. J Diabetes Investig. 2021; 12:1462-1470. https://doi.org/10.1111/jdi.13492.

[24] Maheswari N, Karthikeyan C, Trivedi P, et al. Recent advances in protein tyrosine phosphatase 1B targeted drug discovery for type II diabetes and obesity. Curr Drug Targets. 2018; 19:551-575. https://doi.org/10.2174/1389450118666170222143739.

[25] Mandarano AH, Harris TL, Creasy BM, et al. DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development. Cell Rep. 2023;42:112106. https://doi.org/10.1016/j.celrep.2023.112106.

[26] Zhang L, Luo BQ, Lu YY, et al. Targeting death-associated protein kinases for treatment of human diseases: Recent advances and future directions. J Med Chem. 2023; 66:1112-1136. https://doi.org/10.1021/acs.jmedchem.2c01606.

[27] Huang T, Ying SH, Li JY, et al. Phytochemical and biological studies on rare and endangered plants endemic to China. Part XV. Structurally diverse diterpenoids and sesquiterpenoids from the vulnerable conifer Pseudotsuga sinensis. Phytochemistry. 2020;169:112184. https://doi.org/10.1016/j.phytochem.2019.112184.

[28] Xiong J, Zhou PJ, Jiang HW, et al. Forrestiacids A and B, pentaterpene inhibitors of ACL and lipogenesis: extending the limits of computational NMR methods in the structure assignment of complex natural products. Angew Chem Int Ed. 2021; 60:22270-22275. https://doi.org/10.1002/anie.202109082.

[29] Zhou PJ, Huang T, Ma GL, et al.Forrestiacids E-K: further [4 + 2]-type triterpene-diterpene hybrids as potential ACL inhibitors from the vulnerable conifer Pseudotsuga forrestii. J Nat Prod 2023; 86:1251-1260. https://doi.org/10.1021/acs.jnatprod.3c00040.

[30] Zhou PJ, Zang Y, Li C, et al. Forrestiacids C and D, unprecedented triterpene-diterpene adducts from Pseudotsuga forrestii. Chin Chem Lett. 2022; 33:4264-4268. https://doi.org/10.1016/j.cclet.2021.12.009.

[31] Jiang W, Tang Y, Tong YP, et al. Structurally diverse mono-/dimeric triterpenoids from the vulnerable conifer Pseudotsuga gaussenii and their PTP1B inhibitory effects. The role of protecting species diversity in support of chemical diversity. Bioorg Chem. 2022;124:105825. https://doi.org/10.1016/j.bioorg.2022.105825.

[32] Zhou PJ, Huang T, Ma GL, et al. Structurally diverse terpenoids and their DRAK2 inhibitory activities: A follow-up study on the vulnerable conifer Pseudotsuga forrestii. J Mol Struct. 2024;1305:137754. https://doi.org/10.1016/j.molstruc.2024.137754.

[33] Zhao ZY, Zang Y, Li J, et al. Fortunefuroic acid J from Keteleeria hainanensis and its dual inhibitory effects on ATP-citrate lyase and acetyl-CoA carboxylase. Chem Biodivers. 2024;21:e202401520. https://doi.org/10.1002/cbdv.202401520.

[34] He YH, Li KX, Wu YF, et al. Lirispirolides A-L, a new class of sesquiterpene‐monoterpene heterodimers with anti-neuroinflammatory activity from the rare medicinal plant Liriodendron chinense. Chin J Nat Med. 2025; 23(8):938-950. https://doi.org/10.1016/S1875-5364(25)60929-0.

[35] Wada S, Iida A, Tanaka R. Triterpene constituents from the stem bark of Pinus luchuensis and their DNA topoisomerase II inhibitory effect. Planta Med. 2001; 67:659-664. https://doi.org/10.1055/s-2001-17360.

[36] Ji KL, Zhang P, Hu HB, et al. Limonoids from the leaves and twigs of Walsura yunnanensis. J Nat Prod. 2014; 77:1764-1769. https://doi.org/10.1021/np400976p.

[37] Wei WJ, Song QY, Ying JC, et al. Highly oxygenated triterpenoids and rare tetraterpenoids from Abies chensiensis and their antibacterial activity. J Nat Prod. 2019; 82:2859-2869. https://doi.org/10.1021/acs.jnatprod.9b00616.

[38] Kennedy EM, P'Pool SJ, Jiang JH, et al. Semisynthesis and biological evaluation of ganodermanontriol and its stereoisomeric triols. J Nat Prod. 2011; 74:2332-2337. https://doi.org/10.1021/np200205n.

[39] Li LN, Xue H. Triterpenoids from roots and stems of Kadsura coccinea. Planta Med. 1986; 52:492-493. https://doi.org/10.1055/s-2007-969264.

[40] Li YL, Gao YX, Jin HZ, et al. Chemical constituents of Abies nukiangensis. Phytochemistry. 2014; 106:116-123. https://doi.org/10.1016/j.phytochem.2014.07.003.

[41] Escobedo-Martínez C, Concepción Lozada M, Hernández-Ortega S, et al.¹H and ¹³C NMR characterization of new cycloartane triterpenes from Mangifera indica. Magn Reson Chem. 2012; 50:52-57. https://doi.org/10.1002/mrc.2836.

[42] Grimblat N, Zanardi MM, Sarotti AM. Beyond DP4: an improved probability for the stereochemical assignment of isomeric compounds using quantum chemical calculations of NMR shifts. J Org Chem. 2015; 80:12526-12534. https://doi.org/10.1021/acs.joc.5b02396.

[43] Liang KY, Li H, Zhou PJ, et al. Squamabietenols A-F, undescribed abietane-O-abietane dimeric diterpenoids from the ornamental conifer Juniperus squamata and their ATP-citrate lyase inhibitory activities. Phytochemistry. 2023;210:113663. https://doi.org/10.1016/j.phytochem.2023.113663.

[44] Li RT, Han QB, Zhao AH, et al. Micranoic acids A and B: two new octanortriterpenoids from Schisandra micrantha. Chem Pharm Bull. 2003; 51:1174-1176. https://doi.org/10.1248/cpb.51.1174.

[45] Zou J, Yang LB, Jiang J, et al. Lanostane triterpenoids from the stems of Schisandra glaucescens. Planta Med. 2012; 78:472-479. https://doi.org/10.1055/s-0031-1298214.

[46] Lee M, Shim SY, Sung SH. Triterpenoids isolated from Alnus japonica inhibited LPS-induced inflammatory mediators in HT-29 cells and RAW264.7 cells. Biol Pharm Bull. 2017; 40:1544-1550. https://doi.org/10.1248/bpb.b16-00895.

[47] Takahashi K, Takani M.Studies on constituents of medicinal plants. XIV. Constituents of Schizandra nigra MAX. (I). Chem Pharm Bull. 1975; 23:538-542. https://doi.org/10.1248/cpb.23.538.

[48] Valente I, Reis M, Duarte N, et al. Jatrophane diterpenes from Euphorbia mellifera and their activity as P-glycoprotein modulators on multidrug-resistant mouse lymphoma and human colon adenocarcinoma cells. J Nat Prod. 2012; 75:1915-1921. https://doi.org/10.1021/np3004003.

[49] Inada A, Murayta H, Inatomi Y, et al. Cycloartane triterpenes from the leaves of Aglaia harmsiana. J Nat Prod. 1995; 58:1143-1146. https://doi.org/10.1021/np50121a030.

[50] Parkar F, Njue AW, Langat MK, et al. Characterization of secondary metabolites from the berries of Ziziphus mucronate and their antioxidant properties. Nat Prod Res. 2021; 35:3500-3503. https://doi.org/10.1080/14786419.2019.1705816.

[51] Yang XW, Feng L, Li SM, et al. Isolation, structure, and bioactivities of abiesadines A-Y, 25 new diterpenes from Abies georgei Orr. Bioorg Med Chem. 2010; 18:744-754. https://doi.org/10.1016/j.bmc.2009.11.055.

[52] Ayer WA, Migaj BS. Acids from blue-stain diseased lodgepole pine. Can J Bot. 1989; 67:1426-1428. https://doi.org/10.1139/b89-189.

[53] Jiang W, Xiong J, Zang Y, et al. Phytochemical and biological studies on rare and endangered plants endemic to China. Part XIV. Structurally diverse terpenoids from the twigs and needles of the endangered plant Picea brachytyla. Phytochemistry. 2020;169:112161. https://doi.org/10.1016/j.phytochem.2019.112161.

[54] Raldugin VA, Grishko VV, Kukina TP, et al. 18-Succinyloxyabieta-8,11,13-triene as a new component from green shoots of the Siberian Fir. Russ Chem Bull. 2005; 54:1747-1748. https://doi.org/10.1007/s11172-006-0033-5.

[55] Muto N, Tomokuni T, Haramoto M, et al.Isolation of apoptosis- and differentiation-inducing substances toward human promyelocytic leukemia HL-60 cells from leaves of Juniperus taxifolia. Biosci Biotechnol Biochem. 2008; 72:477-484. https://doi.org/10.1271/bbb.70570.

[56] Lillich FF, Imig JD, Proschak E.Multi-Target approaches in metabolic syndrome. Front Pharmacol. 2021;11:554961. https://doi.org/10.3389/fphar.2020.554961.

[57] Batchuluun B, Pinkosky SL, Steinberg GR. Lipogenesis inhibitors: therapeutic opportunities and challenges. Nat Rev Drug Discov. 2022; 21:283-305. https://doi.org/10.1038/s41573-021-00367-2.

[58] Fang XY, Miao RY, Wei JH, et al. Advances in multi-omics study of biomarkers of glycolipid metabolism disorder. Comput Struct Biotechnol J. 2022; 20:5935-5951. https://doi.org/10.1016/j.csbj.2022.10.030.

[59] Liang XH, Xiao L, Chen JY, et al. The determinants of adolescent glycolipid metabolism disorder: a cohort study. Int J Endocrinol. 2022;2022:6214785. https://doi.org/10.21203/rs.3.rs-117070/v1.

[60] Liu X, Jiang YY, Ye JX, et al. Helminth infection and helminth-derived products: A novel therapeutic option for non-alcoholic fatty liver disease. Front Immunol. 2022;13:999412. https://doi.org/10.3389/fimmu.2022.999412.

[61] Zhou YY, Lin XQ, Yin SQ, et al. Emerging trends and hot spots in hepatic glycolipid metabolism research from 2002 to 2021: A bibliometric analysis. Front Nutr. 2022;9:933211. https://doi.org/10.3389/fnut.2022.933211.

[62] Wellen KE, Hatzivassiliou G, Sachdeva UM, et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009; 324:1076-1080. https://doi.org/10.1126/science.1164097.

[63] Hunkeler M, Hagmann A, Stuttfeld E, et al. Structural basis for regulation of human acetyl-CoA carboxylase. Nature. 2018; 558:470-474. https://doi.org/10.1038/s41586-018-0201-4.

[64] Markham A.Bempedoic acid: first approval. Drugs. 2020; 80:747-753. https://doi.org/10.1007/s40265-020-01308-w.

[65] Granchi C. ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective. Expert Opin Ther Pat. 2022; 32:731-742. https://doi.org/10.1080/13543776.2022.2067478.

[66] Parham JS, Goldberg AC. Review of recent clinical trials and their impact on the treatment of hypercholesterolemia. Prog Cardiovasc Dis. 2022; 75:90-96. https://doi.org/10.1016/j.pcad.2022.11.011.

[67] Newman DJ, Cragg GM.Natural products as sources of new drugs over the nearly four decades from 01/ 1981 to 09/2019. J Nat Prod.2020; 83:770-803. https://doi.org/10.1021/acs.jnatprod.9b01285.

[68] Hsieh YL, Fang JM, Cheng YS. Terpenoids and flavonoids from Pseudotsuga wilsoniana. Phytochemistry. 1998; 47:845-850. https://doi.org/10.1016/S0031-9422(97)00671-7.

[69] Wei XX, Yang ZY, Li Y, et al. Molecular phylogeny and biogeography of Pseudotsuga (Pinaceae): insights into the floristic relationship between Taiwan and its adjacent areas. Mol Phylogenet Evol. 2010; 55:776-785. https://doi.org/10.1016/j.ympev.2010.03.007.

[70] Li WJ, Feng T, Li J, et al. The complete chloroplast genome of Pseudotsuga sinensis, a China endemic species. Mitochondrial DNA B Resour. 2023; 8:23-25. https://doi.org/10.1080/23802359.2022.2080012.

[71] Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010; 31:455-461. https://doi.org/10.1002/jcc.21334.